Date | Return on Equity (ROE) | Return on Capital Employed (ROCE) | Interest Coverage Ratio | Debt to Equity Ratio |
---|
CEO | Dr. Kevin J. Knopp Ph.D. |
IPO Date | Dec. 18, 2020 |
Location | United States |
Headquarters | 645 Summer Street |
Employees | 230 |
Sector | Technology |
Industries |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Past 5 years
USD 2.78
USD 67.36
USD 18.25
USD 88.32
USD 70.99
USD 396.07
USD 5.72
USD 128.22
USD 90.82
USD 79.87
USD 105.02
USD 155.28
USD 4.40
StockViz Staff
February 7, 2025
Any question? Send us an email